Patent holdings for IPC class A61K 31/713

Total number of patents in this class: 8396

10-year publication summary

535
618
620
592
602
782
648
629
664
539
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Alnylam Pharmaceuticals, Inc.
1180
422
Arrowhead Pharmaceuticals, Inc.
354
135
The Regents of the University of California
20815
101
University of Massachusetts
2324
100
Ionis Pharmaceuticals, Inc.
955
84
Nitto Denko Corporation
8558
83
Inserm (institut National de La Sante et de La Recherche Medicale)
3330
67
Regeneron Pharmaceuticals, Inc.
4786
61
Dicerna Pharmaceuticals, Inc.
180
56
Centre National de La Recherche Scientifique
11059
53
The General Hospital Corporation
4875
49
Suzhou Ribo Life Science Co., Ltd.
144
49
Shanghai Argo Biopharmaceutical Co., Ltd.
68
47
Institut National de La Sante et de La Recherche Medicale (inserm)
3275
45
Novartis AG
10173
44
Immunomedics, Inc.
239
44
The Johns Hopkins University
5913
43
Arbutus Biopharma Corporation
161
42
Tuojie Biotech (Shanghai) Co., Ltd.
107
40
Northwestern University
3557
35
Other owners 6796